Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Ford (F) Picks Austin To Test & Rollout Self-Driving Cars

Published 09/26/2019, 10:02 PM
Updated 07/09/2023, 06:31 AM

Ford Motor Company (NYSE:F) has selected Austin, TX, as the third city to test and deploy self-driving vehicles. It plans to launch automated commercial vehicles in 2021. Initially, Ford and its autonomous vehicle subsidiary Agro AI will start mapping the streets of downtown Austin. Later, it will carry out data validation and on-road testing.

There are two primary reasons why Austin was selected. The first being the city’s willingness to work with Ford and second, the rising population of the city which is making it congested. Crowded streets will help the company address issues and understand the obstacles in the city.

Ford and Agro AI formerly declared Miami and Washington DC as the other launch markets.

At first, the self-driving vehicles will have “test specialists” who will drive the vehicle. After the vehicles map the city and gather all data, they will operate autonomously.

The company plans to introduce a model for autonomous driving without pedals or steering wheels that are intended for use in commercial fleet.

Ford’s strategy to launch self-driving vehicles in multiple cities is different from that of General Motors (NYSE:GM) Cruise and Alphabet Inc. (NASDAQ:GOOGL) Waymo. Cruise and Waymo are focusing on a single city before they venture out.

Ford is actively working to introduce newer models of autonomous vehicles. These initiatives are likely to enhance the prospects of this Zacks Rank #2 (Buy) firm. Few months back, Ford announced a partnership with Volkswagen (DE:VOWG_p) AG (OTC:VWAGY) under which the latter will invest $2.6 billion in the U.S. auto giant’s autonomous-car partner. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Alphabet Inc. (GOOGL): Free Stock Analysis Report

Ford Motor Company (F): Free Stock Analysis Report

General Motors Company (GM): Free Stock Analysis Report

Volkswagen AG (VWAGY): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.